This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Torquay, GB (2012 - 2013)
- Cheshire, GB (2014)
Company Filing History:
Years Active: 2012-2014
Title: Cherylin Francis Preston: Innovator in Chemokine Receptor Modulation
Introduction
Cherylin Francis Preston is a notable inventor based in Torquay, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of chemokine receptor modulators. With a total of three patents to his name, Preston's work is recognized for its potential impact on treating various chemokine-mediated diseases and disorders.
Latest Patents
Preston's latest patents include innovative compounds that are designed to act as chemokine receptor modulators. One of his notable inventions is a compound of formula (I), which can exist as a pharmaceutically acceptable salt, solvate, or in vivo hydrolysable ester. This compound, along with pharmaceutical compositions comprising it, is aimed at providing therapeutic solutions for chemokine-mediated diseases and disorders.
Career Highlights
Cherylin Francis Preston is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on groundbreaking research and development in the pharmaceutical sector. His expertise in chemokine receptor modulation has positioned him as a key player in the field.
Collaborations
Preston has collaborated with several esteemed colleagues, including David R Cheshire and Rhona Jane Cox. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of research in their shared field.
Conclusion
Cherylin Francis Preston is a distinguished inventor whose work in chemokine receptor modulation holds promise for the treatment of various diseases. His contributions to the pharmaceutical industry through his patents and collaborations underscore his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile